Cetaphil® Taps Rachel Brosnahan as Creative Consultant for New “Up Close and Sensitive” Digital Campaign

FORT WORTH, Texas, Oct. 13, 2020 /PRNewswire/ — Cetaphil, the #1 dermatologist-recommended facial skincare brand, is excited to announce its plans to expand its current partnership with award-winning actress and star of The Marvelous Mrs. Maisel, Rachel Brosnahan. Brosnahan will continue her role as face of the sensitive skincare brand, while adding new credentials to her repertoire such as Creative Consultant for Cetaphil’s new “Up Close and Sensitive” digital campaign.

In the video content series, Brosnahan will take the consumer through her personal sensitive skincare journey, as well as showcase products for all skin types that meet the needs of women with sensitive skin. The content series will appear across marketing efforts and cross-channel on Cetaphil.com[1] and the brand’s new Amazon storefront[2], making it even easier to shop her trusted favorites. She will also support new product innovation developed by the brand that will be available online and in stores this month.

“Our ongoing partnership with Rachel is all about reaching women like her, who want a healthy, simple routine that fits the needs of even the most sensitive skin,” says Michael Sabbia, Marketing Director of Cetaphil. “We recognize that consumers with sensitive skin want to find products they trust, and we believe this new campaign will help bring those people to the brand and provide them with gentle yet effective solutions for a range of skin concerns. We are very happy with how this genuine relationship continues to evolve.”

Last year, Cetaphil announced signing Brosnahan to a one-year deal that has since been renewed.

“I’m excited to continue working with a brand that I have trusted for my sensitive skin for the better part of a decade,” says Brosnahan. “This partnership has been truly collaborative from the start and I look forward to another great year of working together and empowering others to discover Cetaphil products that work for them.”

Specifically formulated for all sensitive skin types, Cetaphil has become one of the top skincare brands recommended and trusted by dermatologists and other healthcare professionals around the world. The brand is dedicated to bringing new, innovative products to the market to meet the needs of all sensitive skin types and launched several new products this fall, with more to come.

For access to Rachel’s Cetaphil regimen, new launch alerts, and skincare tips, follow her on Instagram at @RachelBrosnahan and follow along at @CetaphilUS with hashtag #MyCetaphilStory.

For additional information, visit www.cetaphil.com[3].

About Cetaphil®
Over seventy years ago, a leading pharmacist created the first Cetaphil product – a gentle, yet powerful formula that would clean without stripping skin and moisturize without clogging pores. Today, Cetaphil is the #1 dermatologist-recommended facial skincare brand and is recognized around the world. With the help of leading global skincare experts, they continue to develop innovative skincare technologies for sensitive skin that help restore, protect, and maintain skin’s health every day. For more information, visit www.cetaphil.com[4].

About Galderma
Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically defined and medically proven solutions for the skin. For more information, please visit www.galderma.com/us[5].

View original content to download multimedia: http://www.prnewswire.com/news-releases/cetaphil-taps-rachel-brosnahan-as-creative-consultant-for-new-up-close-and-sensitive-digital-campaign-301146656.html[6]

SOURCE Galderma Laboratories

Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.

1 2